JP2015530868A5 - - Google Patents

Download PDF

Info

Publication number
JP2015530868A5
JP2015530868A5 JP2015520775A JP2015520775A JP2015530868A5 JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5 JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5
Authority
JP
Japan
Prior art keywords
ifi27
level
gene product
patient
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520775A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015530868A (ja
JP6097388B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/000765 external-priority patent/WO2014008545A1/en
Publication of JP2015530868A publication Critical patent/JP2015530868A/ja
Publication of JP2015530868A5 publication Critical patent/JP2015530868A5/ja
Application granted granted Critical
Publication of JP6097388B2 publication Critical patent/JP6097388B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520775A 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化 Expired - Fee Related JP6097388B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902954 2012-07-10
AU2012902954A AU2012902954A0 (en) 2012-07-10 Risk stratification in influenza
PCT/AU2013/000765 WO2014008545A1 (en) 2012-07-10 2013-07-10 Risk stratification in influenza

Publications (3)

Publication Number Publication Date
JP2015530868A JP2015530868A (ja) 2015-10-29
JP2015530868A5 true JP2015530868A5 (https=) 2016-06-16
JP6097388B2 JP6097388B2 (ja) 2017-03-15

Family

ID=49915252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520775A Expired - Fee Related JP6097388B2 (ja) 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化

Country Status (10)

Country Link
US (2) US10036075B2 (https=)
EP (1) EP2872891B1 (https=)
JP (1) JP6097388B2 (https=)
KR (1) KR20150040289A (https=)
CN (1) CN104769430B (https=)
AU (1) AU2013289854B2 (https=)
BR (1) BR112015000685A2 (https=)
CA (1) CA2877400A1 (https=)
DK (1) DK2872891T3 (https=)
WO (1) WO2014008545A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108802385B (zh) 2012-02-09 2022-02-08 米密德诊断学有限公司 用于诊断感染的标记和决定因素和其使用方法
WO2015103664A1 (en) * 2014-01-09 2015-07-16 Nepean Blue Montains Local Health District Risk stratification in influenza
BR112017002884A2 (pt) 2014-08-14 2018-01-30 Memed Diagnostics Ltd ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
CN107209184B (zh) 2014-12-11 2020-04-24 米密德诊断学有限公司 用于诊断多种感染的标记组合及其使用方法
EP3146974A1 (en) 2015-09-25 2017-03-29 Universite Claude Bernard - Lyon 1 Biomarkers for early determination of severity of influenza related disease
IL294121B2 (en) 2016-03-03 2023-09-01 Memed Diagnostics Ltd An RNA test to diagnose the type of infection
EP3423590A4 (en) 2016-03-03 2020-02-26 Memed Diagnostics Ltd. DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
US11385241B2 (en) 2016-09-29 2022-07-12 Memed Diagnostics Ltd. Methods of prognosis and treatment
US12344893B2 (en) 2018-06-05 2025-07-01 Washington University Nasal genes used to identify, characterize, and diagnose viral respiratory infections
US20230176074A1 (en) * 2020-04-09 2023-06-08 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792626A (en) * 1996-09-18 1998-08-11 Incyte Pharmaceuticals, Inc. Human interferon-inducible protein
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
KR20070052694A (ko) * 2004-01-09 2007-05-22 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 유전자 발현을 위한 세포-유형-특이적 패턴
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
WO2007034280A2 (en) * 2005-09-19 2007-03-29 Moshe Amihood Blay Composition and method for prevention of influenza
CA2695935A1 (en) * 2006-08-11 2008-02-28 Baylor Research Institute Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
WO2009148150A1 (ja) * 2008-06-06 2009-12-10 国立大学法人富山大学 インフルエンザウィルス検出用デバイス
EP2808402A3 (en) * 2008-12-29 2015-03-25 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Methods of predicting responsiveness to interferon treatment
WO2011008349A2 (en) * 2009-05-26 2011-01-20 Duke University Methods of identifying infectious disease and assays for identifying infectious disease
US20140004565A1 (en) * 2009-07-06 2014-01-02 Alnylam Pharmaceuticals, Inc. Cell-based bioprocessing
WO2011038363A2 (en) * 2009-09-28 2011-03-31 The Regents Of The University Of California Beta-defensin 2 genetic variation predicts h. pylori susceptibility
WO2013030841A1 (en) 2011-09-04 2013-03-07 Yissum Research Development Company Of The Hebrew Universitiy Of Jerusalem Ltd. Prognostic methods and compositions for predicting interferon treatment eficacy in a subject

Similar Documents

Publication Publication Date Title
JP2015530868A5 (https=)
TWI329742B (https=)
CN1910456B (zh) 视神经脊髓炎的标记
JP2017184729A5 (https=)
US10859573B2 (en) Nourin molecular biomarkers diagnose angina patients with negative troponin
JP6755241B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP2012512389A5 (https=)
KR20110014979A (ko) 항바이러스 요법
Guan et al. Epidemiological investigation of feline infectious peritonitis in cats living in Harbin, Northeast China from 2017 to 2019 using a combination of an EvaGreen-based real-time RT-PCR and serum chemistry assays
JP2017519498A5 (https=)
JP7463351B2 (ja) 脳卒中の血液バイオマーカー
JP2011524977A (ja) ループスのためのバイオマーカー
JP2013508719A5 (https=)
EP3346270A1 (en) Composition for diagnosing infectious diseases or infectious complications by using tryptophanyl-trna synthetase and method for detecting diagnostic marker
JP2015505245A (ja) 川崎病のためのバイオマーカー
JP2015505245A5 (https=)
EP4053557A1 (en) Il-29 as a marker for a pancreatic disease
Ghazzi et al. Impact of SARS-COV-2 variants on the infection severity among Iraqi patients
JP6420475B2 (ja) 細気管支炎後の喘息の診断のためのマーカーおよびその用途
JPWO2019117269A1 (ja) 膵がんの検出を補助する方法
JP2008167714A (ja) 川崎病発症のリスク因子
JP2008547006A5 (https=)
Kaysheva et al. Mass spectrometric detection of the amino acid sequence polymorphism of the hepatitis C virus antigen
JP2012521549A5 (https=)
JP2005291899A (ja) 心疾患の検査法